Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Coherus Biosciences Inc (NASDAQ:CHRS)

35.39
Delayed Data
As of Jul 29
 -0.70 / -1.94%
Today’s Change
12.27
Today|||52-Week Range
38.10
+116.85%
Year-to-Date
No recent news for Coherus Biosciences Inc.

Today’s Trading

Previous close36.09
Today’s open36.04
Day’s range-- - --
Volume163,015
Average volume (3 months)307,661
Market cap$1.4B
Dividend yield--
Data as of 07/29/2015

Growth & Valuation

Earnings growth (last year)-10.14%
Earnings growth (this year)+70.68%
Earnings growth (next 5 years)--
Revenue growth (last year)+1,030.72%
P/E ratioNM
Price/Sales4.30
Price/Book17.97

Competitors

 Today’s
change
Today’s
% change
MCRBSeres Therapeutics I...+1.20+3.29%
RLYPRelypsa Inc-0.58-1.67%
MNTAMomenta Pharmaceutic...-0.47-2.10%
AXONAxovant Sciences Ltd-1.09-6.83%
Data as of 07/29/2015

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$31.1M
Annual profit (last year)-$87.1M
Net profit margin-280.12%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Denny M. Lanfear
Chief Financial Officer
Jean-Frédéric Viret
Corporate headquarters
Redwood City, California

Forecasts